Evaluation of Serum Biomarkers for Patients at Increased Risk of Stroke
Table 1
Patients characteristics.
Asym/stable*
Asym/unstable
Sym/stable*
Sym/unstable
value**
of 110
of 110
of 110
of 110
Age (years)
0.210
Sex (male/female)
14/11
29/7
9/4
22/24
0.140
Associated diseases
Coronary heart disease
40.0
46.8
27.3
30.3
0.491
Hypertension
90.5
87.5
90.9
78.8
0.586
Chronic kidney disease
4.8
9.3
9.1
3.1
0.724
Diabetes mellitus
14.3
37.5
27.3
18.2
0.106
Medication
ASA/clopidogrel
100.0
96.8
100.0
100.0
0.573
Beta-blockers
65.0
74.2
72.7
65.6
0.860
ACE inhibitors
35.0
51.6
45.4
46.9
0.322
Statins
70.0
54.8
54.5
64.1
0.212
Age: mean ± standard deviation; all other values are in % of the study subjects within the each group; ASA: Acetyl salicylic acid.
*Asym: asymptomatic patients, Sym: symptomatic patients.
**One-way ANOVA (analysis of variance) was used.
